BRIEFING:  The following Investment Summary was extracted from documentation produced by Fogleman, Rich & Rose, under contract from Company management, and was used to informally "test the water" immediately prior to a private offering of unregistered securities.   The Firm subsequently produced a matched set of Business Plan and Private Placement Memorandum which was successfully used by Soma during its raise of $2 million.  The Placement was completed and no offer is currently being undertaken by Soma Longevity Centres.

      SOMA LONGEVITY CENTRES of FLORIDA, L.L.C. ("SLC" or the "Company") is a Florida based Limited Liability Corporation formed for the purpose of creating a Nationally Licensed System of Life Extension and Complementary Medicine Clinics, dedicated to a comprehensive ANTI-AGING Therapy Program, serving both males and females.

      The Company plans to purchase and expand a prominent local medical practice. The Practice specializes in life extension therapies based on nutrition and life-style modification, but also includes the delivery of a large variety of what has been called by some medical authorities “Complementary Medicine". Therapies such as Chiropractic, Acupuncture and Chelation are among the services currently offered. The clinic and its staff are operating at an increasing capacity, with a strong demand of new patients requesting treatment.

GROWTH PLAN

      The Company plans to purchase a new, two story building for the practice, renaming it Soma Longevity Centres of Florida. The Company plans to open at least five additional Soma Centres within the next nine months. The Company also expects to License the Soma Longevity Concept, opening 24 centers in the second year and up to 36 more in year three.

      Using the world renowned pharmaceutical and formulative expertise of Director James Jamieson, Jr., the Company intends to develop and market certain nonprescription health aids and remedies, some of which will be sold at retail through the life extension centres and other outlets.

      The Existing Centre offers a range of therapies, some are already reimbursable under Medicare and various insurance policies and some are more “alternative” in nature.

      The current range of therapies offered at the Clinic will be expanded and all therapies will be marketed to its appropriate demographic segment. Foremost among the New Complementary Medicines to be offered are:

      1. The ViroPauseR Treatment - Reversing impotence - Impotence is almost as common as the ordinary cold, but it is much more treatable. Medical surveys indicate that 30 million American men suffer needlessly as up to 95% of these sufferers can be treated. The Soma Centres can help them have a healthy sex life, treating a cause of much anguish, tension and malaise.

      2. DHEA Therapy - Recent research indicates that DHEA may be a critical link to good health. DHEA is a natural substance that the body can convert into estrogen, progesterone, testosterone and other hormones - but only when the body naturally requires such conversion. DHEA is nontoxic and has no known side effects.

      3. Feminine Hormonal Replacement Therapy - The Clinic will provide therapy for alleviation of several feminine conditions including the bodily reactions to menopause, PMS, osteoporosis and others. Entry into this rapidly growing field will open an entire new range of services for the Soma Centres.

THE RIGHT TEAM

      Soma Longevity Centres of Florida has in place an experienced and motivated management team of seasoned professionals with a complete and well researched marketing and financial plan ready to implement. Detailed biographies are a part of this plan.

CAPITALIZATION PLAN

      Currently, management seeks investment capital in exchange for stock in the Company which will soon own the practice (with three years reviewed financial statements) and the real estate. The Company intends to raise up to two million dollars of primary expansion capital from private investors. At some time in the future, management expects that the Company will go public via initial offer (if marketplace conditions permit) or through a reverse merger with an existing public entity, conducting an aggressive investor relations and market maker promotion.

INCOME AND REVENUE PROJECTIONS

      A detailed financial analysis of the existing practice has been coupled with the experiential input of the Company’s Board of Directors to produce the Company's projections of growth and earnings.

      In the development of Centre Incomes, the current plan is to add five locations to the Existing Centre, with the assumptions that the six would grow over the next 36 months to about 1.5 million dollars each in annual sales.

      Jim Jamieson would likely, in the near future, introduce a line of mineral, vitamin, and nutritional supplements designed to enhance the lives of patients, and this would further add income to the venture. These additional potential revenues have not been considered in the Company’s projected earnings.

      As currently projected, over the next three years, the Company will generate over fourteen million dollars in profits on total income of about thirty million dollars. Market research indicates the potential to increase roll-out speed and market penetration under the impetus of a secondary capital infusion which could triple the above projections.

      At this writing, the Soma Private Placement Memorandum is near completion and Senior Operating Management is standing by. With initial planning completed, all the elements are in place to envision the development of the Soma Longevity Centres Concept into...